 | • レポートコード：MRC2012B0838 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、MSD治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。MSD治療の種類別市場規模（OTC、処方薬）、用途別市場規模（病院、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Roche、Amgen、Johnson & Johnson、Eli Lilly、Pfizer Inc、 ・地域別グローバル市場分析 2015年-2020年 ・MSD治療の北米市場（アメリカ、カナダ、メキシコ） ・MSD治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・MSD治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・MSD治療の南米市場（ブラジル、アルゼンチン） ・MSD治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：OTC、処方薬 ・用途別分析：病院、小売薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global MSD Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The MSD Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
MSD Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, MSD Treatment market has been segmented into:
OTC
Rx Drugs
By Application, MSD Treatment has been segmented into:
Hospital
Retail Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global MSD Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level MSD Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global MSD Treatment market.
The report offers in-depth assessment of the growth and other aspects of the MSD Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and MSD Treatment Market Share Analysis
MSD Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, MSD Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the MSD Treatment sales, revenue and market share for each player covered in this report.
The major players covered in MSD Treatment are:
AbbVie
Roche
Amgen
Johnson & Johnson
Eli Lilly
Pfizer Inc
Table of Contents
1 MSD Treatment Market Overview
1.1 Product Overview and Scope of MSD Treatment
1.2 Classification of MSD Treatment by Type
1.2.1 Global MSD Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global MSD Treatment Revenue Market Share by Type in 2019
1.2.3 OTC
1.2.4 Rx Drugs
1.3 Global MSD Treatment Market by Application
1.3.1 Overview: Global MSD Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global MSD Treatment Market by Regions
1.4.1 Global MSD Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of MSD Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) MSD Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) MSD Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) MSD Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) MSD Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) MSD Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie MSD Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche MSD Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen MSD Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson MSD Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly MSD Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer Inc
2.6.1 Pfizer Inc Details
2.6.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer Inc SWOT Analysis
2.6.4 Pfizer Inc Product and Services
2.6.5 Pfizer Inc MSD Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global MSD Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 MSD Treatment Players Market Share
3.2.2 Top 10 MSD Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global MSD Treatment Revenue and Market Share by Regions
4.2 North America MSD Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe MSD Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific MSD Treatment Revenue and Growth Rate (2015-2020)
4.5 South America MSD Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa MSD Treatment Revenue and Growth Rate (2015-2020)
5 North America MSD Treatment Revenue by Countries
5.1 North America MSD Treatment Revenue by Countries (2015-2020)
5.2 USA MSD Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada MSD Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico MSD Treatment Revenue and Growth Rate (2015-2020)
6 Europe MSD Treatment Revenue by Countries
6.1 Europe MSD Treatment Revenue by Countries (2015-2020)
6.2 Germany MSD Treatment Revenue and Growth Rate (2015-2020)
6.3 UK MSD Treatment Revenue and Growth Rate (2015-2020)
6.4 France MSD Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia MSD Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy MSD Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific MSD Treatment Revenue by Countries
7.1 Asia-Pacific MSD Treatment Revenue by Countries (2015-2020)
7.2 China MSD Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan MSD Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea MSD Treatment Revenue and Growth Rate (2015-2020)
7.5 India MSD Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia MSD Treatment Revenue and Growth Rate (2015-2020)
8 South America MSD Treatment Revenue by Countries
8.1 South America MSD Treatment Revenue by Countries (2015-2020)
8.2 Brazil MSD Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina MSD Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue MSD Treatment by Countries
9.1 Middle East & Africa MSD Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia MSD Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE MSD Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt MSD Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa MSD Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global MSD Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global MSD Treatment Market Forecast by Type (2019-2024)
10.3 OTC Revenue Growth Rate (2015-2025)
10.4 Rx Drugs Revenue Growth Rate (2015-2025)
11 Global MSD Treatment Market Segment by Application
11.1 Global MSD Treatment Revenue Market Share by Application (2015-2020)
11.2 MSD Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Retail Pharmacy Revenue Growth (2015-2020)
12 Global MSD Treatment Market Size Forecast (2021-2025)
12.1 Global MSD Treatment Market Size Forecast (2021-2025)
12.2 Global MSD Treatment Market Forecast by Regions (2021-2025)
12.3 North America MSD Treatment Revenue Market Forecast (2021-2025)
12.4 Europe MSD Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific MSD Treatment Revenue Market Forecast (2021-2025)
12.6 South America MSD Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa MSD Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global MSD Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of MSD Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global MSD Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market MSD Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AbbVie Corporate Information, Location and Competitors
Table 6. AbbVie MSD Treatment Major Business
Table 7. AbbVie MSD Treatment Total Revenue (USD Million) (2017-2018)
Table 8. AbbVie SWOT Analysis
Table 9. AbbVie MSD Treatment Product and Solutions
Table 10. AbbVie MSD Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Roche Corporate Information, Location and Competitors
Table 12. Roche MSD Treatment Major Business
Table 13. Roche MSD Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Roche SWOT Analysis
Table 15. Roche MSD Treatment Product and Solutions
Table 16. Roche MSD Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Amgen Corporate Information, Location and Competitors
Table 18. Amgen MSD Treatment Major Business
Table 19. Amgen MSD Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Amgen SWOT Analysis
Table 21. Amgen MSD Treatment Product and Solutions
Table 22. Amgen MSD Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Johnson & Johnson Corporate Information, Location and Competitors
Table 24. Johnson & Johnson MSD Treatment Major Business
Table 25. Johnson & Johnson MSD Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Johnson & Johnson SWOT Analysis
Table 27. Johnson & Johnson MSD Treatment Product and Solutions
Table 28. Johnson & Johnson MSD Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Eli Lilly Corporate Information, Location and Competitors
Table 30. Eli Lilly MSD Treatment Major Business
Table 31. Eli Lilly MSD Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Eli Lilly SWOT Analysis
Table 33. Eli Lilly MSD Treatment Product and Solutions
Table 34. Eli Lilly MSD Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Pfizer Inc Corporate Information, Location and Competitors
Table 36. Pfizer Inc MSD Treatment Major Business
Table 37. Pfizer Inc MSD Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Pfizer Inc SWOT Analysis
Table 39. Pfizer Inc MSD Treatment Product and Solutions
Table 40. Pfizer Inc MSD Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global MSD Treatment Revenue (Million USD) by Players (2015-2020)
Table 42. Global MSD Treatment Revenue Share by Players (2015-2020)
Table 43. Global MSD Treatment Revenue (Million USD) by Regions (2015-2020)
Table 44. Global MSD Treatment Revenue Market Share by Regions (2015-2020)
Table 45. North America MSD Treatment Revenue by Countries (2015-2020)
Table 46. North America MSD Treatment Revenue Market Share by Countries (2015-2020)
Table 47. Europe MSD Treatment Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific MSD Treatment Revenue (Million USD) by Countries (2015-2020)
Table 49. South America MSD Treatment Revenue by Countries (2015-2020)
Table 50. South America MSD Treatment Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa MSD Treatment Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa MSD Treatment Revenue Market Share by Countries (2015-2020)
Table 53. Global MSD Treatment Revenue (Million USD) by Type (2015-2020)
Table 54. Global MSD Treatment Revenue Share by Type (2015-2020)
Table 55. Global MSD Treatment Revenue Forecast by Type (2021-2025)
Table 56. Global MSD Treatment Revenue by Application (2015-2020)
Table 57. Global MSD Treatment Revenue Share by Application (2015-2020)
Table 58. Global MSD Treatment Revenue Forecast by Application (2021-2025)
Table 59. Global MSD Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. MSD Treatment Picture
Figure 2. Global MSD Treatment Revenue Market Share by Type in 2019
Figure 3. OTC Picture
Figure 4. Rx Drugs Picture
Figure 5. MSD Treatment Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Retail Pharmacy Picture
Figure 8. Global MSD Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America MSD Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe MSD Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific MSD Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America MSD Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa MSD Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global MSD Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global MSD Treatment Revenue Share by Players in 2019
Figure 16. Global Top 5 Players MSD Treatment Revenue Market Share in 2019
Figure 17. Global Top 10 Players MSD Treatment Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global MSD Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global MSD Treatment Revenue Market Share by Regions (2015-2020)
Figure 21. Global MSD Treatment Revenue Market Share by Regions in 2018
Figure 22. North America MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 23. Europe MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 25. South America MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 27. North America MSD Treatment Revenue Market Share by Countries (2015-2020)
Figure 28. North America MSD Treatment Revenue Market Share by Countries in 2019
Figure 29. USA MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Canada MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Mexico MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Europe MSD Treatment Revenue Market Share by Countries (2015-2020)
Figure 33. Europe MSD Treatment Revenue Market Share by Countries in 2019
Figure 34. Germany MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 35. UK MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 36. France MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Russia MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Italy MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific MSD Treatment Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific MSD Treatment Revenue Market Share by Countries in 2019
Figure 41. China MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Japan MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Korea MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 44. India MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 46. South America MSD Treatment Revenue Market Share by Countries (2015-2020)
Figure 47. South America MSD Treatment Revenue Market Share by Countries in 2019
Figure 48. Brazil MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Argentina MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa MSD Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa MSD Treatment Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 53. UAE MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Egypt MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 55. South Africa MSD Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Global MSD Treatment Revenue Share by Type (2015-2020)
Figure 57. Global MSD Treatment Revenue Share by Type in 2019
Figure 58. Global MSD Treatment Market Share Forecast by Type (2021-2025)
Figure 59. Global OTC Revenue Growth Rate (2015-2020)
Figure 60. Global Rx Drugs Revenue Growth Rate (2015-2020)
Figure 61. Global MSD Treatment Revenue Share by Application (2015-2020)
Figure 62. Global MSD Treatment Revenue Share by Application in 2019
Figure 63. Global MSD Treatment Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospital Revenue Growth Rate (2015-2020)
Figure 65. Global Retail Pharmacy Revenue Growth Rate (2015-2020)
Figure 66. Global MSD Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global MSD Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global MSD Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America MSD Treatment Revenue Market Forecast (2021-2025)
Figure 70. Europe MSD Treatment Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific MSD Treatment Revenue Market Forecast (2021-2025)
Figure 72. South America MSD Treatment Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa MSD Treatment Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…- 白血病治療薬の世界市場（～2026年） Leukemia Treatment Drugs is used to cure Leukemia. Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market. Market Analysis and Insights: Global Leukemia Treatment Drugs Market The glob…
- ドラベ症候群治療の世界市場（～2026年） Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells. Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include …
- 筋骨格系障害治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Musculoskeletal Disorders Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Musculosk…
- 酒さ治療の世界市場（～2026年） Rosacea is a chronic skin disease that generally affects the white population. Rising demand from European region is a major driver for the growth of the Rosacea Treatment market. Market Analysis and Insights: Global Rosacea Treatment Market The global Rosacea Treatment market size is projected to r…